However, the authors failed to evaluate statistically significant results between the analyzed subgroups, and concluded that serum CXCL5 cannot be recognized as a potential marker in CRC, although CXCL15 concentrations increased with disease stage and correlated with poor survival [64,65]. This evidence concerns the gene CXCL5 and colorectal carcinoma.